This video is a recording of our View Point webinar from February 21, 2023. In this webinar, join FBC and Dr. Tom Sheidow for a discussion about the current state of therapies for dry and wet AMD. We will cover types of treatments, treatment outcomes and what is coming in the future.
View Point is proudly presented by Bayer and supported by Abbvie, AGTC, Apellis, Janssen, MeriaGTx, Novartis and Roche.
To learn more visit www.fightingblindness.ca/get-...
STAY CONNECTED
Facebook: / fightingblindnesscanada
Instagram: / fightingblindnessca
LinkedIn: / fighting-blindness-canada
Sign-up for our monthly e-newsletter: www.fightingblindness.ca/enew...
CONTACT US
General Inquiries: info@fightingblindness.ca
Health Information Line: 1.888.626.2995 | healthinfo@fightingblindness.ca
ABOUT FIGHTING BLINDNESS CANADA
Fighting Blindness Canada (FBC) is Canada’s leading private funder of vision research. We offer hope to Canadians by identifying the best, most promising research that is driving treatments and cures for blinding eye diseases, and by raising and stewarding funds to support this essential, sight-saving research. All of the research and educational initiatives we fund, support our goals of understanding why vision loss occurs, how it can be slowed or stopped, and how sight can be restored. Learn more about Fighting Blindness Canada: www.fightingblindness.ca/abou...
DONATE: Support the advancement of sight-saving research, make a donation today: bit.ly/42ItLtg
Негізгі бет The Age-Related Macular Degeneration (AMD) Clinical Trial Landscape
Пікірлер